Cholinesterase inhibitors slow decline in function in Alzheimer's Disease (AD): A 2-year observational study in the Sunnybrook dementia cohort

被引：0
|
作者：
Behl, P
Lanctot, K
Streiner, D
Black, S
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [41] A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer’s disease
    Roberto Raschetti
    Marina Maggini
    Giacoma Carla Sorrentino
    Nello Martini
    Bruno Caffari
    Nicola Vanacore
    European Journal of Clinical Pharmacology, 2005, 61 : 361 - 368
  • [42] Walking and the 2-year risk of functional decline: An observational study of US adults with arthritis
    Cisternas, Miriam G.
    Murphy, Louise B.
    Carlson, Susan A.
    PREVENTIVE MEDICINE, 2019, 119 : 100 - 107
  • [43] One year cohort study: The difference of subjective and objective autonomic function in Alzheimer's disease and dementia with Lewy bodies and normal subjects
    Wang, Carol Sheei-Meei
    Ouyang, Wen-Chen
    Ho, Hsueh-Jen
    Chen, Pai-Lien
    Chien, Pei-Fang
    Hou, Nien-Tsen
    Huang, Ying-Che
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 : S133 - S134
  • [44] A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease
    Raschetti, R
    Maggini, M
    Sorrentino, GC
    Martini, N
    Caffari, B
    Vanacore, N
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) : 361 - 368
  • [45] Predictors of dementia in Parkinson's disease: A prospective observational cohort study
    Anang, J. B. M.
    Postuma, R. B.
    Bertrand, J. -A.
    Gagnon, J. -F.
    Romenets, S. Rios
    Panisset, M.
    Montplaisir, J.
    MOVEMENT DISORDERS, 2014, 29 : S335 - S335
  • [46] A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes
    Charbonneau, Claudie
    Massoud, Fadi
    Dorais, Marc
    LeLorier, Jacques
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3287 - 3294
  • [47] Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's Disease and their carers
    Smith, Bethany
    Chur-Hansen, Anna
    Neale, Alice
    Symon, Jonathon
    AUSTRALASIAN PSYCHIATRY, 2008, 16 (06) : 433 - 437
  • [48] Treatment of Alzheimer's disease with cholinesterase inhibitors in Germany: A cost-effectiveness study
    Faltraco, F
    Happich, M
    Reisig, V
    Teipel, SJ
    Moeller, HJ
    Hampel, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S336 - S336
  • [49] CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients
    Clarelli, Ferdinando
    Mascia, Elisabetta
    Santangelo, Roberto
    Mazzeo, Salvatore
    Giacalone, Giacomo
    Galimberti, Daniela
    Fusco, Federica
    Zuffi, Marta
    Fenoglio, Chiara
    Franceschi, Massimo
    Scarpini, Elio
    Forloni, Gianluigi
    Magnani, Giuseppe
    Comi, Giancarlo
    Albani, Diego
    Boneschi, Filippo Martinelli
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 (04) : 1203 - 1208
  • [50] Factors predictive of institutionalization in a population based cohort of Alzheimer's disease patients dispensed cholinesterase inhibitors
    Amuah, Joseph E.
    Hogan, David B.
    Eliasziw, Michael
    Supina, Alison
    Beck, Patricia
    Downey, Winnane
    Maxwell, Colleen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S193 - S194
12345